血管ステントの世界市場：製品タイプ、材料、送達システム、用途、エンドユーザー別-2025-2030年予測

血管ステント市場の2023年の市場規模は100億9,000万米ドルで、2024年には106億5,000万米ドルに成長し、CAGRは5.88%、2030年には150億6,000万米ドルに達すると予測されています。

世界中のヘルスケアシステムが心血管および末梢血管疾患の大きな負担に対処し続けているため、血管ステント市場は新たな重要性を帯びてきています。技術革新と臨床ニーズが交錯する環境において、この市場は高度な治療介入を支える重要な柱へと発展しています。

現在進行中のステント留置技術の開発は、単に手技の安全性と有効性の向上にとどまらず、個別化医療、低侵襲技術、急速な技術導入といった幅広い動向を反映しています。高齢化が進み、冠動脈疾患、消化管合併症、末梢動脈疾患などの有病率が顕著に増加する中、信頼性が高く革新的な血管ステントに対する需要の増加は明らかです。

本分析では、このダイナミックな市場を包括的に概観します。まず、近年見られる進化の背景と根拠を明確にすることから始めます。マクロ経済動向と、変革の波の先陣を切ったミクロレベルのシフトの両方に注目し、セグメンテーション、地域ダイナミクス、競合情勢を詳細に調査するための舞台を整えます。

血管ステント市場における変革の波

血管ステント市場の変革は、見逃すことのできないエネルギーをもって展開されています。デバイスデリバリーシステムにおける継続的な技術革新、材料科学の進歩、規制改革はすべて、これらのデバイスの構想、製造、臨床応用の方法を再定義しています。近年では、ステントに次世代機能を組み込む方向へのシフトが顕著であり、耐久性や生体適合性を高めるだけでなく、患者のニーズに合わせて治療効果を提供する製品への道が開かれつつあります。

薬剤溶出機能や生体吸収性材料などの技術的飛躍的進歩は、性能と安全性において新たな基準を打ち立てた。ポリマー科学の急速な開発は、先進的なポリマー製ステント、特に生分解性設計のステントの台頭に貢献し、永久インプラントに伴う長期的リスクの軽減が期待されています。同時に、デジタル技術と遠隔健康モニタリング技術の進化は、医師が術後のケアについてより多くの情報に基づいた決定を下せる環境を醸成し、患者の転帰を大幅に改善しました。

世界の規制と政策改革も、この進化に重要な役割を果たしています。これらの規制改革は、製品承認に拍車をかけ、革新的な機器を市場に投入するための経路を合理化し、画期的な技術がいかに早く臨床現場に到達できるかに直接影響を与えています。加えて、研究開発への投資の増加や業界各社の戦略的提携が、技術革新と商業化のサイクルを加速させています。

このような変革的な変化は、より統合され、テクノロジーを駆使し、患者を中心としたヘルスケアへのアプローチを目指す、より広範な動きを象徴するものです。こうした動向が市場に浸透し続ける中、臨床転帰の向上、手技介入の効率化、そして業界全体にとっての持続可能な前進を実現することに引き続き焦点が当てられています。

血管ステントエコシステムにおける主要セグメント分析

血管ステント市場を詳細に調査すると、セグメンテーションのレンズを通して重要な洞察が明らかになります。製品タイプに基づく分析によると、市場はバルーン拡張型ステントと自己拡張型ステントに大別され、両カテゴリーは特定の臨床ニーズや手技の嗜好に対応しています。この分類は、各ステントタイプに関連する最適な適用設定と固有の性能特性の概要を示すものであり、極めて重要です。

さらに材料構成に目を向けると、セグメンテーションは金属ステントと高分子ステントに分類される二重アプローチを反映しています。生分解性ポリマーと非生分解性ポリマーを区別することで、ポリマー技術の可能性が高まります。生分解性ポリマーは、永久的なインプラントの長期的なリスクや合併症を軽減する能力で人気を集めているためです。

デリバリーシステムはまた、ベアメタルステント、カバードステント、ドラッグ溶出ステントのスペクトルを詳述することにより、説得力のあるセグメント化物語を提示しています。各デリバリー機構は、手技の容易さと治療効果という点で独自の利点を具現化しており、中でも薬剤溶出ステントは、再狭窄を阻止する局所的な薬物療法と機械的サポートを組み合わせることで大きな可能性を提供しています。

さらに、用途に基づくセグメンテーションを分析する場合、冠動脈疾患、消化器疾患、末梢動脈疾患などの主要な疾患に焦点が当てられます。これらのうち最後のものは、下肢と上肢を区別することでさらにニュアンスを増しており、これは複雑な解剖学的および生理学的状況において、テーラーメイドのソリューションの必要性を例証しています。最後に、エンドユーザーに基づくセグメンテーションでは、外来手術センター、心臓センター、病院など、さまざまな設定が示されます。このエンドユーザー分析により、高度なステント留置術ソリューションを採用し導入する可能性が最も高い流通チャネルとヘルスケアインフラが明らかになり、市場浸透と成長のための明確なロードマップが得られます。

これらのセグメンテーションはそれぞれ、市場力学を重層的に理解することに貢献し、製品開拓、流通チャネルの最適化、臨床関与の強化のための的を絞った戦略を促進します。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 心血管疾患の世界的蔓延
    • 低侵襲手術の導入増加
  • 抑制要因
    • ヘルスケア従事者の間では血管ステントの長期的な有効性と安全性に関する懸念が高まっている
  • 機会
    • ステント設計の革新に向けた研究開発活動への投資の増加
    • 血管ステントにスマートテクノロジーを統合し、安全性と有効性を向上
  • 課題
    • 厳格な規制基準と承認手続きに伴う複雑さ
• 市場セグメンテーション分析
  • 製品タイプ：複雑な動脈経路をナビゲートする際の精度と有効性のために、バルーン拡張型ステントがますます好まれるようになっています。
  • 材料：血管の開存性を維持する耐久性と有効性により、金属ステントの利用が増加しています。
  • デリバリーシステム：慢性疾患や複雑な病変の管理における有効性により、薬剤溶出ステントがますます好まれるようになっている
  • 用途：低侵襲手術の必要性から、冠動脈疾患（CAD）における血管ステントの適用が拡大
  • エンドユーザー：高品質のケアと迅速な回復のために、外来手術センターで血管ステントの採用が増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 血管ステント市場：製品タイプ別

• バルーン拡張型ステント
• 自己拡張型ステント

第7章 血管ステント市場：素材別

• 金属ステント
• ポリマーステント
  • 生分解性ポリマー
  • 非生分解性ポリマー

第8章 血管ステント市場配信システム別

• ベアメタルステント
• カバー付きステント
• 薬剤溶出ステント

第9章 血管ステント市場：用途別

• 冠動脈疾患
• 胃腸疾患
• 末梢動脈疾患
  • 下肢
  • 上肢

第10章 血管ステント市場：エンドユーザー別

• 外来手術センター
• 心臓センター
• 病院

第11章 南北アメリカの血管ステント市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の血管ステント市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの血管ステント市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析, 2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Amaranth Medical, Inc.
• Artivion Inc.
• B. Braun SE
• Becton, Dickinson and Company
• Biotronik SE & Co. KG
• Blue Sail Medical Co., Ltd
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cook Group Incorporated
• Elixir Medical Corporation
• Endologix LLC
• iVascular, S.L.U
• Kaneka Corporation
• Kyoto Medical Planning Co., Ltd.
• Lepu Medical Technology（Beijing）Co.,Ltd.
• Lombard Medical Ltd.
• Medtronic PLC
• Meril Life Sciences Pvt. Ltd
• Microport Scientific Corporation
• Otsuka Medical Devices Co., Ltd.
• Purple MicroPort Cardiovascular Pvt. Ltd
• Sahajanand Medical Technologies Limited
• Stryker Corporation
• Terumo Corporation
• Translumina GmbH
• W. L. Gore & Associates, Inc.

LIST OF FIGURES

• FIGURE 1. VASCULAR STENT MARKET MULTI-CURRENCY
• FIGURE 2. VASCULAR STENT MARKET MULTI-LANGUAGE
• FIGURE 3. VASCULAR STENT MARKET RESEARCH PROCESS
• FIGURE 4. VASCULAR STENT MARKET SIZE, 2023 VS 2030
• FIGURE 5. GLOBAL VASCULAR STENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL VASCULAR STENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL VASCULAR STENT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL VASCULAR STENT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL VASCULAR STENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 17. GLOBAL VASCULAR STENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. AMERICAS VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES VASCULAR STENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 21. UNITED STATES VASCULAR STENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 26. VASCULAR STENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 27. VASCULAR STENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VASCULAR STENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VASCULAR STENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VASCULAR STENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VASCULAR STENT MARKET DYNAMICS
• TABLE 7. GLOBAL VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VASCULAR STENT MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VASCULAR STENT MARKET SIZE, BY SELF-EXPANDING STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VASCULAR STENT MARKET SIZE, BY METALLIC STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VASCULAR STENT MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VASCULAR STENT MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL VASCULAR STENT MARKET SIZE, BY BARE METAL STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL VASCULAR STENT MARKET SIZE, BY COVERED STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL VASCULAR STENT MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL VASCULAR STENT MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL VASCULAR STENT MARKET SIZE, BY GASTROINTESTINAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL VASCULAR STENT MARKET SIZE, BY LOWER EXTREMITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL VASCULAR STENT MARKET SIZE, BY UPPER EXTREMITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL VASCULAR STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL VASCULAR STENT MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL VASCULAR STENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. CANADA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. CANADA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 55. CANADA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 56. CANADA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 57. CANADA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. CANADA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 59. CANADA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES VASCULAR STENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. AUSTRALIA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 84. AUSTRALIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 85. AUSTRALIA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 86. AUSTRALIA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 87. AUSTRALIA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 89. AUSTRALIA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. CHINA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. CHINA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 92. CHINA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 93. CHINA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 94. CHINA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. CHINA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 96. CHINA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. INDIA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. INDIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 99. INDIA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 100. INDIA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 101. INDIA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. INDIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 103. INDIA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. INDONESIA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 105. INDONESIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 106. INDONESIA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 107. INDONESIA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 108. INDONESIA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. INDONESIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 110. INDONESIA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. JAPAN VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 112. JAPAN VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 113. JAPAN VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 114. JAPAN VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 115. JAPAN VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. JAPAN VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 117. JAPAN VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. MALAYSIA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 119. MALAYSIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 120. MALAYSIA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 121. MALAYSIA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 122. MALAYSIA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. MALAYSIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 124. MALAYSIA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. PHILIPPINES VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 126. PHILIPPINES VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 127. PHILIPPINES VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 128. PHILIPPINES VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 129. PHILIPPINES VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. PHILIPPINES VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 131. PHILIPPINES VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. SINGAPORE VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SINGAPORE VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 134. SINGAPORE VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 135. SINGAPORE VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 136. SINGAPORE VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. SINGAPORE VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 138. SINGAPORE VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 140. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 141. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 142. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 143. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 145. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. TAIWAN VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 147. TAIWAN VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 148. TAIWAN VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 149. TAIWAN VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 150. TAIWAN VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. TAIWAN VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 152. TAIWAN VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 153. THAILAND VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 154. THAILAND VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 155. THAILAND VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 156. THAILAND VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 157. THAILAND VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. THAILAND VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 159. THAILAND VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 160. VIETNAM VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 161. VIETNAM VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 162. VIETNAM VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 163. VIETNAM VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 164. VIETNAM VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. VIETNAM VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 166. VIETNAM VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 167. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 168. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 169. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 170. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 171. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 175. DENMARK VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 176. DENMARK VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 177. DENMARK VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 178. DENMARK VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 179. DENMARK VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. DENMARK VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 181. DENMARK VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 182. EGYPT VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 183. EGYPT VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 184. EGYPT VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 185. EGYPT VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 186. EGYPT VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. EGYPT VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 188. EGYPT VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 189. FINLAND VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 190. FINLAND VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 191. FINLAND VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 192. FINLAND VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 193. FINLAND VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. FINLAND VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 195. FINLAND VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 196. FRANCE VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 197. FRANCE VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 198. FRANCE VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 199. FRANCE VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 200. FRANCE VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 201. FRANCE VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 202. FRANCE VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 203. GERMANY VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 204. GERMANY VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 205. GERMANY VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 206. GERMANY VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 207. GERMANY VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 208. GERMANY VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 209. GERMANY VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 210. ISRAEL VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 211. ISRAEL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 212. ISRAEL VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 213. ISRAEL VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 214. ISRAEL VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. ISRAEL VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 216. ISRAEL VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 217. ITALY VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 218. ITALY VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 219. ITALY VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 220. ITALY VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 221. ITALY VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. ITALY VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 223. ITALY VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 224. NETHERLANDS VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 225. NETHERLANDS VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 226. NETHERLANDS VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 227. NETHERLANDS VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 228. NETHERLANDS VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. NETHERLANDS VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 230. NETHERLANDS VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 231. NIGERIA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 232. NIGERIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 233. NIGERIA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 234. NIGERIA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 235. NIGERIA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 236. NIGERIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 237. NIGERIA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 238. NORWAY VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 239. NORWAY VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 240. NORWAY VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 241. NORWAY VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 242. NORWAY VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 243. NORWAY VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 244. NORWAY VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 245. POLAND VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 246. POLAND VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 247. POLAND VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 248. POLAND VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 249. POLAND VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 250. POLAND VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 251. POLAND VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 252. QATAR VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 253. QATAR VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 254. QATAR VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 255. QATAR VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 256. QATAR VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 257. QATAR VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 258. QATAR VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 259. RUSSIA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 260. RUSSIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 261. RUSSIA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 262. RUSSIA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 263. RUSSIA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 264. RUSSIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 265. RUSSIA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 266. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 267. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 268. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 269. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 270. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 271. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 272. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 273. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 274. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 275. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 276. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 277. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 278. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 279. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 280. SPAIN VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 281. SPAIN VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 282. SPAIN VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 283. SPAIN VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 284. SPAIN VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 285. SPAIN VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 286. SPAIN VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 287. SWEDEN VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 288. SWEDEN VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 289. SWEDEN VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 290. SWEDEN VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 291. SWEDEN VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 292. SWEDEN VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 293. SWEDEN VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 294. SWITZERLAND VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 295. SWITZERLAND VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 296. SWITZERLAND VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 297. SWITZERLAND VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 298. SWITZERLAND VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 299. SWITZERLAND VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 300. SWITZERLAND VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 301. TURKEY VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 302. TURKEY VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 303. TURKEY VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 304. TURKEY VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 305. TURKEY VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 306. TURKEY VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 307. TURKEY VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 308. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 309. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 310. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 311. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 312. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 313. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 314. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 315. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 316. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 317. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
• TABLE 318. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
• TABLE 319. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 320. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
• TABLE 321. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 322. VASCULAR STENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 323. VASCULAR STENT MARKET, FPNV POSITIONING MATRIX, 2023

The Vascular Stent Market was valued at USD 10.09 billion in 2023 and is projected to grow to USD 10.65 billion in 2024, with a CAGR of 5.88%, reaching USD 15.06 billion by 2030.

The vascular stent market has taken on new importance as healthcare systems around the globe continue to address the significant burden of cardiovascular and peripheral vascular diseases. In an environment where innovation intersects with clinical need, this market has evolved into a critical pillar that supports advanced therapeutic interventions.

The ongoing development of stenting technologies is not merely confined to improvements in procedural safety and efficacy, but it also mirrors the broader trends of personalized medicine, minimally invasive techniques, and rapid technological adoption. With an aging population and a marked increase in the prevalence of conditions such as coronary artery disease, gastrointestinal complications, and peripheral arterial disease, the increased demand for reliable and innovative vascular stents is palpable.

This analysis offers a comprehensive overview of the dynamic market. It begins by establishing a clear context and rationale for the evolution witnessed over recent years. It draws attention to both macroeconomic trends and micro-level shifts that have spearheaded a wave of transformative changes, setting the stage for an in-depth exploration of segmentation, regional dynamics, and competitive landscapes.

Transformative Shifts in the Vascular Stent Market

The transformation of the vascular stent market unfolds with an energy that is unmissable. Ongoing innovations in device delivery systems, material science advancements, and regulatory reforms have all redefined the way these devices are conceived, manufactured, and clinically applied. In recent years, there has been a marked shift towards integrating next-generation features into stents, making way for products that not only enhance durability and biocompatibility but also offer tailored therapeutic benefits according to patient needs.

Technological breakthroughs, such as drug-eluting capabilities and bioresorbable materials, have set new benchmarks in performance and safety. Fast-tracked developments in polymer science have contributed to the rise of advanced polymeric stents, particularly those designed to be biodegradable, which promise to mitigate long-term risks associated with permanent implants. Simultaneously, the evolution of digital and remote health monitoring technologies has fostered an environment where physicians can make more informed decisions about post-procedural care, significantly improving patient outcomes.

Global regulations and policy reforms have also played a crucial role in this evolution. These regulatory changes have spurred product approvals and streamlined pathways for introducing innovative devices to the market, directly impacting how quickly groundbreaking technologies can reach clinical settings. In addition, increased investments in research and development along with strategic collaborations among industry players have accelerated the cycle of innovation and commercialization.

The transformative shifts are emblematic of a broader move towards a more integrated, technology-enabled, and patient-centric approach to healthcare. As these trends continue to permeate the market, the focus remains on delivering enhanced clinical outcomes, efficiency in procedural interventions, and a sustainable path forward for the industry at large.

Key Segmentation Insights in the Vascular Stent Ecosystem

An in-depth examination of the vascular stent market reveals significant insights through the lens of segmentation. An analysis based on product type indicates that the market is largely partitioned into balloon-expandable stents and self-expanding stents, with both categories catering to specific clinical needs and procedural preferences. This classification is crucial as it outlines the optimal application settings and the inherent performance characteristics associated with each stent type.

Looking further into the material composition, the segmentation reflects a dual approach that is categorized into metallic stents and polymeric stents. The opportunity within polymeric technology is enhanced by distinguishing between biodegradable and non-biodegradable polymers. This aspect of segmentation not only highlights the clinical versatility and performance but also underpins the strategic research focus, as biodegradable polymers are gaining traction for their capability to reduce the long-term risks and complications of permanent implants.

The delivery system also presents a compelling segmentation narrative by detailing the spectrum of bare metal stents, covered stents, and drug-eluting stents. Each delivery mechanism embodies unique advantages in terms of procedural ease and therapeutic effectiveness, with drug-eluting variants offering significant promise by combining mechanical support with localized drug therapy to thwart restenosis.

Furthermore, when analyzing application-based segmentation, the focus rests on key conditions including coronary artery disease, gastrointestinal disease, and peripheral artery disease. The last of these is further nuanced by distinguishing between lower extremities and upper extremities, which exemplifies the need for tailored solutions in complex anatomical and physiological contexts. Finally, segmentation based on the end-user presents an array of settings such as ambulatory surgical centers, cardiac centers, and hospitals. This end-user analysis underscores the distribution channels and the healthcare infrastructure that is most likely to adopt and implement advanced stenting solutions, thereby providing a clear roadmap for market penetration and growth.

Each of these segmentation facets contributes to a layered understanding of the market dynamics, facilitating targeted strategies for product development, distribution channel optimization, and enhanced clinical engagement.

Based on Product Type, market is studied across Balloon-Expandable Stents and Self-Expanding Stents.

Based on Material, market is studied across Metallic Stents and Polymeric Stents. The Polymeric Stents is further studied across Biodegradable Polymers and Non-Biodegradable Polymers.

Based on Delivery System, market is studied across Bare Metal Stents, Covered Stents, and Drug Eluting Stents.

Based on Application, market is studied across Coronary Artery Disease, Gastrointestinal Disease, and Peripheral Artery Disease. The Peripheral Artery Disease is further studied across Lower Extremities and Upper Extremities.

Based on End User, market is studied across Ambulatory Surgical Centers, Cardiac Centers, and Hospitals.

Regional Dynamics Steering Market Growth

The geographical landscape in which the vascular stent market operates is as diverse as the clinical applications it serves. Across the Americas, there is a strong prevalence of cardiovascular and peripheral vascular diseases, which drives significant demand for advanced stent technologies. In addition, investments in state-of-the-art healthcare facilities and an increasing focus on minimally invasive procedures solidify the region's role as a key market for innovative stenting solutions.

In the Europe, Middle East & Africa region, the emphasis on quality healthcare combined with supportive regulatory frameworks has led to steady market expansion. The regulatory environment in these areas is characterized by clear guidelines and robust approval processes, which in turn fosters a competitive market landscape for both established and emerging companies. Public and private healthcare collaborations along with consistent R&D investments further underpin the region's growth.

Meanwhile, the Asia-Pacific region is notable for its rapid urbanization and rising standards of healthcare. The segment is witnessing accelerated adoption of innovative medical devices spurred by governmental support and evolving clinical infrastructures. As emerging economies continue to invest in advanced healthcare technologies, both the demand and supply of vascular stents are expected to continue trending upward. This region has shown an appetite for breakthrough technologies that promise both efficacy and cost-efficiency, which in turn drives significant market opportunities.

Altogether, these regional insights highlight the importance of localized market strategies that account for diverse healthcare infrastructures, economic conditions, and regulatory environments. The interplay of these factors determines how each region adapts and leverages new technologies in the fight against vascular diseases.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Competitive Landscape and Leading Company Insights

A detailed competitive analysis reveals an intricate tapestry of industry leaders who have progressively shaped the market. Renowned players such as Abbott Laboratories, Amaranth Medical, Inc., and Artivion Inc. have established strongholds in product innovation and market penetration. Their relentless focus on research, development, and clinical validation has set the stage for significant advancements in stenting technologies.

Other companies such as B. Braun SE, Becton, Dickinson and Company, and Biotronik SE & Co. KG have also contributed actively to expanding the product portfolio. These organizations not only leverage deep clinical insights but also capitalize on strategic alliances that dovetail with the evolving needs of healthcare providers. Firms like Blue Sail Medical Co., Ltd, in conjunction with Boston Scientific Corporation and Cardinal Health, Inc., have placed a significant emphasis on integrating advanced delivery systems and specialized stent materials that cater to diverse clinical requirements.

The competitive momentum is further buoyed by contributors such as Cook Group Incorporated, Elixir Medical Corporation, and Endologix LLC. These companies focus on refining the mechanics of stent deployment and optimizing patient outcomes by addressing multifactorial clinical challenges. Innovators like iVascular, S.L.U and Kaneka Corporation have brought to the market novel biocompatibility solutions that emphasize both functionality and safety.

Not to be overlooked are the visionary roles played by Kyoto Medical Planning Co., Ltd., Lepu Medical Technology (Beijing) Co., Ltd., and Lombard Medical Ltd. Their strategic investments in research and geographic expansions have enabled these players to secure vital market positions. Medtronic PLC and Meril Life Sciences Pvt. Ltd, along with other key players such as Microport Scientific Corporation, Otsuka Medical Devices Co., Ltd., and Purple MicroPort Cardiovascular Pvt. Ltd, continue to push the envelope with ground-breaking clinical trials and product innovations.

Additional notable insights are driven by companies including Sahajanand Medical Technologies Limited, Stryker Corporation, Terumo Corporation, Translumina GmbH, and W. L. Gore & Associates, Inc. Together, these industry leaders create a competitive ecosystem where rigorous performance benchmarks, innovative delivery systems, and diversified product offerings drive market growth and continuous improvements in patient care.

The report delves into recent significant developments in the Vascular Stent Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amaranth Medical, Inc., Artivion Inc., B. Braun SE, Becton, Dickinson and Company, Biotronik SE & Co. KG, Blue Sail Medical Co., Ltd, Boston Scientific Corporation, Cardinal Health, Inc., Cook Group Incorporated, Elixir Medical Corporation, Endologix LLC, iVascular, S.L.U, Kaneka Corporation, Kyoto Medical Planning Co., Ltd., Lepu Medical Technology(Beijing)Co.,Ltd., Lombard Medical Ltd., Medtronic PLC, Meril Life Sciences Pvt. Ltd, Microport Scientific Corporation, Otsuka Medical Devices Co., Ltd., Purple MicroPort Cardiovascular Pvt. Ltd, Sahajanand Medical Technologies Limited, Stryker Corporation, Terumo Corporation, Translumina GmbH, and W. L. Gore & Associates, Inc.. Actionable Recommendations for Industry Leaders

Leaders in the vascular stent market should adopt a multi-dimensional strategy to remain at the forefront of this evolving landscape. First, investing in advanced research and development is crucial for staying ahead of market trends and meeting the nuanced needs of patients. It is essential to focus on refining both material composition and device design to further improve safety profiles and clinical outcomes. Recognizing the shift towards biodegradable polymers and drug-eluting technologies can incentivize future innovations that cater to personalized treatment strategies.

Next, forging robust partnerships with key clinical institutions and pivotal thought leaders can enhance the depth of clinical insights while also expanding product reach. Collaborations with regulatory experts will likely streamline market entry and accelerate approval processes in various regions. In doing so, companies can not only reduce time-to-market but also broaden their portfolio through well-integrated product lines.

Investing in digitization and data analytics is another key recommendation. By leveraging big data, real-time monitoring, and predictive analytics, industry leaders can better understand customer needs, track post-market performance, and preemptively address potential product issues. This strategic integration of digital solutions can empower decision-makers with actionable insights and foster more informed clinical decisions.

Finally, there is high strategic value in adopting a region-specific market approach. Tailoring products and marketing strategies to align with localized clinical practices and regulatory norms serves as a robust pathway to tapping into the unique opportunities within the Americas, Europe, Middle East & Africa, and Asia-Pacific. Embracing such a multi-pronged strategy can position industry leaders to capture emerging market segments and to anticipate shifts in global demand effectively.

Conclusion: Navigating a Dynamic Future in Vascular Stents

In summary, the vascular stent market continues to undergo profound transformations driven by technological advancements, regulatory changes, and evolving clinical demands. The intricate segmentation based on product type, material, delivery systems, and application categories provides a comprehensive view of the competitive nuances influencing the industry. Further, the regional analyses across the Americas, Europe, Middle East & Africa, and Asia-Pacific highlight both opportunities and challenges that are unique to each area.

The convergence of innovation, regulatory evolution, and strategic commercial initiatives promises a dynamic future for the market. Companies that remain agile, invest in robust research, and emphasize digital integrations will likely set the benchmark for future advancements. Ultimately, the trajectory of the market reaffirms the substantial role that vascular stents continue to play in modern medical interventions.

As research deepens and the market matures, stakeholders are encouraged to align their strategic priorities with emerging trends, sustainable innovations, and targeted market-driven approaches. This comprehensive perspective not only underscores the importance of advanced stent technologies but also lays the groundwork for a more resilient and patient-centric healthcare ecosystem.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Expanding global prevalence of cardiovascular diseases
    • 5.1.1.2. Increasing adoption of minimally invasive surgeries
  • 5.1.2. Restraints
    • 5.1.2.1. Concerns related to the long-term efficacy and safety of vascular stents among healthcare providers
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising investments in research and development activities for innovation in stent designs
    • 5.1.3.2. Integration of smart technology in vascular stents offering enhanced safety and efficacy
  • 5.1.4. Challenges
    • 5.1.4.1. Complexities associated with the stringent regulatory standards and approval procedures
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type: Growing preference for balloon-expandable stents for precision and effectiveness in navigating complex arterial paths
  • 5.2.2. Material: Increasing utilization of metallic stents owing to their durability and efficacy in maintaining vascular patency
  • 5.2.3. Delivery System: Increasing preference for drug-eluting stents owing to their effectiveness in managing chronic conditions and complex lesions
  • 5.2.4. Application: Expanding applications of vascular stents in coronary artery disease (CAD) owing to the need for minimally invasive procedures
  • 5.2.5. End-Users: Growing adoption of vascular stent in ambulatory surgical centers for high-quality care and rapid recovery
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Vascular Stent Market, by Product Type

• 6.1. Introduction
• 6.2. Balloon-Expandable Stents
• 6.3. Self-Expanding Stents

7. Vascular Stent Market, by Material

• 7.1. Introduction
• 7.2. Metallic Stents
• 7.3. Polymeric Stents
  • 7.3.1. Biodegradable Polymers
  • 7.3.2. Non-Biodegradable Polymers

8. Vascular Stent Market, by Delivery System

• 8.1. Introduction
• 8.2. Bare Metal Stents
• 8.3. Covered Stents
• 8.4. Drug Eluting Stents

9. Vascular Stent Market, by Application

• 9.1. Introduction
• 9.2. Coronary Artery Disease
• 9.3. Gastrointestinal Disease
• 9.4. Peripheral Artery Disease
  • 9.4.1. Lower Extremities
  • 9.4.2. Upper Extremities

10. Vascular Stent Market, by End User

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Cardiac Centers
• 10.4. Hospitals

11. Americas Vascular Stent Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Vascular Stent Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Vascular Stent Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Translumina expands global footprint with UAE operations, leveraging Indian innovation in vascular stents
  • 14.3.2. R3 Vascular Inc. secures USD 87 million funding, and targets breakthrough in PAD treatment with next-gen bioresorbable scaffold
  • 14.3.3. GE HealthCare's 3DStent tackles expansion challenges in complex cases by revolutionizing stent visualization
  • 14.3.4. Artivion amends agreements with Endospan to provide additional funding for FDA approval
  • 14.3.5. Boston Scientific acquires Silk Road Medical to enhance vascular intervention capabilities
  • 14.3.6. Philips launched Duo Venous Stent system to advance innovative solutions in venous outflow obstruction treatment
  • 14.3.7. Kaneka's strategic partnership with Rapid Medical set to revolutionize Japan's stent retriever market with TIGERTRIEVER launch
  • 14.3.8. Strategic partnership between SMT and HeartX to revolutionize congenital heart defect treatment worldwide
  • 14.3.9. Abbott introduces Xience Sierra coronary stent system for enhanced heart patient care
  • 14.3.10. Cook Medical secures DOD Contract, strengthening market position and fostering growth in vascular stent sector
  • 14.3.11. Terumo India advances cardiovascular care with Ultimaster Nagomi Stent launch
  • 14.3.12. Kaneka Corporation acquires Japan Medical Device Technology to revolutionize coronary stent innovation
• 14.4. Strategy Analysis & Recommendation
  • 14.4.1. Stryker Corporation
  • 14.4.2. Medtronic PLC
  • 14.4.3. Boston Scientific Corporation
  • 14.4.4. Abbott Laboratories

Companies Mentioned

• 1. Abbott Laboratories
• 2. Amaranth Medical, Inc.
• 3. Artivion Inc.
• 4. B. Braun SE
• 5. Becton, Dickinson and Company
• 6. Biotronik SE & Co. KG
• 7. Blue Sail Medical Co., Ltd
• 8. Boston Scientific Corporation
• 9. Cardinal Health, Inc.
• 10. Cook Group Incorporated
• 11. Elixir Medical Corporation
• 12. Endologix LLC
• 13. iVascular, S.L.U
• 14. Kaneka Corporation
• 15. Kyoto Medical Planning Co., Ltd.
• 16. Lepu Medical Technology(Beijing)Co.,Ltd.
• 17. Lombard Medical Ltd.
• 18. Medtronic PLC
• 19. Meril Life Sciences Pvt. Ltd
• 20. Microport Scientific Corporation
• 21. Otsuka Medical Devices Co., Ltd.
• 22. Purple MicroPort Cardiovascular Pvt. Ltd
• 23. Sahajanand Medical Technologies Limited
• 24. Stryker Corporation
• 25. Terumo Corporation
• 26. Translumina GmbH
• 27. W. L. Gore & Associates, Inc.